AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.72B
SCIIX
Price
$7.27
Change
+$0.02 (+0.28%)
Updated
Oct 17 closing price
Net Assets
318.33M
Interact to see
Advertisement

AEPCX vs SCIIX

Header iconAEPCX vs SCIIX Comparison
Open Charts AEPCX vs SCIIXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.72B
Virtus SGA International Growth A
Price$7.27
Change+$0.02 (+0.28%)
VolumeN/A
Net Assets318.33M
AEPCX vs SCIIX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. SCIIX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and SCIIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 138B vs. SCIIX (318M). AEPCX pays higher dividends than SCIIX: AEPCX (0.16) vs SCIIX (0.00). AEPCX was incepted earlier than SCIIX: AEPCX (25 years) vs SCIIX (30 years). AEPCX (1.57) is less costly to investors than SCIIX (1.48). AEPCX is a more actively managed with annual turnover of: 35.00 vs. SCIIX (22.00). AEPCX has a lower initial minimum investment than SCIIX: AEPCX (250) vs SCIIX (2500). AEPCX annual gain was more profitable for investors over the last year : 10.02 vs. SCIIX (-21.49). AEPCX return over 5 years is better than : 9.92 vs. SCIIX (-25.81).
AEPCXSCIIXAEPCX / SCIIX
Total Expense Ratio1.571.30121%
Annual Report Gross Expense Ratio1.571.48106%
Fund Existence25 years30 years-
Gain YTD20.6318.996229%
Front LoadN/A6%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets138B318M43,396%
Annual Yield % from dividends0.160.00-
Returns for 1 year10.02-21.49-47%
Returns for 3 years45.85-1.62-2,838%
Returns for 5 years9.92-25.81-38%
Returns for 10 years36.76-26.37-139%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp